Brief: Theraclion Announces First Patients Treated With SONOVEIN
May 11 (Reuters) - Theraclion SA ALTHER.PA :
* ANNOUNCED ON WEDNESDAY FIRST PATIENTS TREATED WITH
THERACLION'S
SONOVEIN IN US
* OUR QUALITATIVE PRE-CLINICAL STUDIES, CE MARKING SINCE
2019 AND
OUR CLINICAL DATA FROM OUR EUROPEAN CENTERS SHOULD SUPPORT A
FAST APPROVAL FOR OUR PIVOTAL STUDY - CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nBw5h26f8a
Further company coverage: ALTHER.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO